Mikrobiomik receives the "Novel Company" award, granted by El Correo and Banco Sabadell

El lunes 20 de febrero, la compañía fue galardonada con el premio “Empresa Novel”, dentro de la entrega Premios Euskadi Avanza, y organizados por el periódico local de mayor importancia El Correo y el Banco Sabadell


Last Monday, February 20th, the company was awarded with the " Novel Company " prize, within the Euskadi Avanza Awards ceremony, organized by the most important local newspaper El Correo and Sabadell Bank. More than three hundred guests, businessmen and institutional representatives, attended the award ceremony of the sixth edition, which took place at the Guggenheim Museum.

The company's CEO, Juan Basterra, together with part of the team, Celia Morales (Technical Director), Igor Calvo (CFO) and Ziortza Ispizua (Production Manager), went up to receive the award. In his speech, Basterra thanked all of his team and insisted that in addition to capital, talent is needed because "it is necessary, no matter how much investment there is, without a team, without talent, there is no project", he said. He also mentioned that they are in a financing round for 9 million euros, in search of capital to support the project that aspires to be the first biopharmaceutical company in the world to market the first biologic medicine based on fecal microbiota at the EU.

EL CORREO also presented the awards for 'Company of the Year' to Gestamp; 'SME of the Year Award' to AVS; and the 'Lifetime Achievement Award' to Amaia Gorostiza. Iñigo Barrenechea, president of the newspaper, emphasized that the award winners have sought permanent improvement by developing a vocation for public service, supported by innovation and competitiveness, attending to the needs of their customers and markets.

Attached files
Mikrobiomik recibe premio Empresa Novel- castellano-inglés.pdf190.41 KBDownload